Completing cancer treatment and turning attention to family-building is a significant milestone — and for many cancer survivors, the desire to have children is among the strongest motivations to pursue and survive treatment. The questions that arise are practical and important: when is it safe to try? Does fertility return after chemotherapy? Does pregnancy increase the risk of cancer recurrence?

This guide focuses on the period after treatment — what is known about fertility return, when IVF is safe to attempt, and what using preserved material looks like in practice.

Does Fertility Return After Cancer Treatment?

Whether ovarian or testicular function recovers after cancer treatment depends on:

What treatment was given. Alkylating chemotherapy agents (cyclophosphamide, busulfan, melphalan) are the most gonadotoxic. Other regimens (many standard breast cancer protocols) are less damaging. Radiotherapy near the gonads or total body irradiation is highly damaging. For detail on gonadotoxicity by treatment type, see fertility preservation before cancer treatment.

Age at time of treatment. Younger patients have a larger ovarian reserve to begin with and are more likely to retain some function after treatment.

Duration and cumulative dose. Higher cumulative doses and longer treatment courses are associated with greater gonadal damage.

For women: Post-treatment recovery of ovarian function (evidenced by return of periods) occurs in a significant proportion of patients, particularly those treated at younger ages with lower-gonadotoxicity regimens. However, the ovarian reserve remaining is typically lower than pre-treatment, and the window of remaining fertility may be compressed. AMH testing after treatment gives the best available estimate of remaining reserve.

For men: Spermatogenesis is typically more sensitive to chemotherapy and radiotherapy than ovarian function. Recovery can take months to years; some men do not recover fertility. Post-treatment semen analysis (at least 12 months after completing treatment) assesses recovery.

When Is It Safe to Try After Cancer Treatment?

This is one of the most important questions, and the answer depends heavily on cancer type and treatment:

General guidance: Most oncologists recommend waiting a minimum of 6–24 months after completing treatment before attempting pregnancy. The most common recommendation is approximately 2 years, based on:

  • The period of highest recurrence risk for most cancers is in the first 2 years
  • Residual effects of chemotherapy on egg and sperm quality resolve over time — sperm DNA fragmentation from chemotherapy typically normalises within 6–12 months; egg quality recovery is less clearly characterised
  • In pregnancy, altered immune and hormonal environment means that a recurrence during pregnancy would be more complex to manage

Cancer-specific timelines:

  • Breast cancer (hormone receptor positive): Adjuvant hormone therapy (tamoxifen, aromatase inhibitors) typically runs for 5–10 years, during which pregnancy is contraindicated. Some women take a planned "treatment break" under oncological guidance to attempt pregnancy, then resume therapy. This is an active area of research (the POSITIVE trial).
  • Haematological malignancies (leukaemia, lymphoma): Usually 2 years post-treatment if in remission; longer if transplant was involved.
  • Cervical, ovarian, and uterine cancers: Complex and case-specific; requires multidisciplinary oncology and fertility specialist input.

Always confirm the recommended interval with your oncologist before attempting pregnancy — your specific cancer type, treatment, and remission status determine the answer.

Using Preserved Material After Cancer Treatment

If eggs, embryos, or sperm were frozen before treatment, using them after cancer treatment is straightforward in procedure but requires coordination:

For frozen eggs: A standard FET cycle protocol is used — oestrogen and progesterone to prepare the endometrium, then thaw, ICSI fertilisation, culture to blastocyst, and transfer. The timing is coordinated with the treating oncologist's clearance to proceed.

For frozen embryos: FET as above, without the fertilisation step. If the embryos were created with a partner who is no longer in the relationship, legal consent issues may arise — consent from the male gamete provider is required for use.

For frozen sperm: Used in IUI, IVF, or ICSI depending on quantity and quality. Long-term frozen sperm can be used decades after banking, with no significant deterioration in viability.

NHS funding: The NHS typically funds the fertility preservation itself but not necessarily the subsequent use of frozen material in fertility treatment. Check with your ICB whether post-cancer fertility treatment is commissioned.

IVF Without Preserved Material

Some cancer survivors did not preserve fertility before treatment — either because they were not offered the opportunity, because treatment was too urgent, or because their fertility was not a priority at diagnosis.

If ovarian function has returned after treatment (evidenced by regular periods and detectable AMH), IVF using own eggs may be possible. Key considerations:

  • AMH and AFC should be tested to assess remaining reserve — reserve after gonadotoxic treatment is often reduced even if periods have returned
  • Stimulation protocols should be tailored to reduced reserve expectations
  • Prompt referral given the compressed remaining fertility window

For patients with impaired or absent ovarian function after treatment, donor egg IVF is the most effective route to pregnancy. See donor egg IVF in the UK.

Does Pregnancy Increase Cancer Recurrence Risk?

This question is one of the most understandable concerns for cancer survivors considering pregnancy. The evidence, which has grown substantially over the past decade, is broadly reassuring:

Breast cancer: Multiple large observational studies (including POSITIVE trial data and meta-analyses) do not show increased recurrence risk from pregnancy after breast cancer. Historically, concerns centred on oestrogen in pregnancy stimulating hormone-receptor-positive cancers, but population data does not support this fear. Most guidelines no longer consider pregnancy contraindicated after breast cancer treatment (with appropriate waiting periods and oncological clearance).

Other cancers: Evidence varies by type, but for many cancers that are successfully treated and in remission, pregnancy is not associated with increased recurrence risk.

Always discuss this specifically with your oncologist for your cancer type and staging.

Frequently Asked Questions

Q: I had chemotherapy 3 years ago. My periods returned but are irregular. Can I still get pregnant?

A: Irregular periods after chemotherapy suggest partial recovery of ovarian function. The best first step is AMH and AFC testing to assess your current reserve. If reserve is still measurable, IVF may be possible. If very low, donor eggs may be the more realistic option. Irregular cycles after treatment do not automatically preclude pregnancy.

Q: I didn't preserve fertility before treatment. What are my options now?

A: If ovarian function has returned (any periods), IVF with own eggs may be worth exploring — get AMH and AFC tested. If ovarian function has not returned (no periods for more than 12 months after treatment), premature ovarian insufficiency has likely occurred and donor egg IVF is the primary path to pregnancy with own uterus. See perimenopause and fertility for related context.

Q: I'm on tamoxifen for breast cancer and want to try for a baby. What should I do?

A: This requires discussion with your oncologist. Taking a planned break from tamoxifen to attempt pregnancy (then resuming) is the subject of ongoing research (the POSITIVE trial). Your oncologist will assess whether a treatment break is appropriate given your cancer type, staging, and current response. Do not stop tamoxifen without oncological guidance.

Q: How do I know if the IVF clinic I see has experience with cancer survivors?

A: Ask specifically. Some fertility centres have oncofertility programmes with close links to oncology departments. Others have more general experience. For complex cases — particularly where the interaction between cancer type and fertility treatment is significant (e.g., oestrogen-sensitive cancers and ovarian stimulation) — seeking a centre with specific oncofertility experience is worthwhile.

Q: Can IVF stimulation cause cancer to recur?

A: For most cancers, the evidence does not support this concern. For oestrogen-sensitive cancers (particularly hormone receptor-positive breast cancer), the high oestrogen levels during IVF stimulation have historically raised theoretical concerns. Modified IVF protocols using letrozole alongside stimulation (to reduce peak oestrogen levels) are used at specialist centres for breast cancer patients undergoing egg freezing. Discuss the specific risks relevant to your cancer type with both your oncologist and fertility specialist.

This article is for information only. Decisions about fertility treatment after cancer should always involve both your oncologist and a fertility specialist with relevant experience.